{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Bronchodilators",
      "COPD and exacerbations",
      "Inhaled corticosteroids"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24507845",
  "DateCompleted": {
    "Year": "2014",
    "Month": "05",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "12",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.ccm.2013.09.009",
      "S0272-5231(13)00139-1"
    ],
    "Journal": {
      "ISSN": "1557-8216",
      "JournalIssue": {
        "Volume": "35",
        "Issue": "1",
        "PubDate": {
          "Year": "2014",
          "Month": "Mar"
        }
      },
      "Title": "Clinics in chest medicine",
      "ISOAbbreviation": "Clin Chest Med"
    },
    "ArticleTitle": "Current drug treatment, chronic and acute.",
    "Pagination": {
      "StartPage": "177",
      "EndPage": "189",
      "MedlinePgn": "177-89"
    },
    "Abstract": {
      "AbstractText": [
        "The appropriate management of chronic obstructive pulmonary disease (COPD) involves more than taking prescription medicines. The key components have been set out in detail in many treatment guidelines, both national and international. They include the avoidance of identified risk factors, especially tobacco smoking, and the optimization of daily physical activity. This article reviews the key components of the pharmacologic treatment of COPD, both acute and chronic, with an emphasis on those recent studies, which are likely to change practice in the next few years."
      ],
      "CopyrightInformation": "Copyright \u00a9 2014 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Respiratory Research, Clinical Sciences Department, Institute of Ageing & Chronic Diseases, University Hospital Aintree, Lower Lane, Liverpool L9 7AL, UK. Electronic address: pmacal@liverpool.ac.uk."
          }
        ],
        "LastName": "Calverley",
        "ForeName": "Peter",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Clin Chest Med",
    "NlmUniqueID": "7907612",
    "ISSNLinking": "0272-5231"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Adrenal Cortex Hormones"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Aminopyridines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Benzamides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Bronchodilator Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cyclopropanes"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Muscarinic Antagonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Phosphodiesterase 4 Inhibitors"
    },
    {
      "RegistryNumber": "0P6C6ZOP5U",
      "NameOfSubstance": "Roflumilast"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Inhalation"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Adrenal Cortex Hormones"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Aminopyridines"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Benzamides"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Bronchodilator Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Cyclopropanes"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Therapy, Combination"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Evidence-Based Medicine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Forced Expiratory Volume"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Muscarinic Antagonists"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Phosphodiesterase 4 Inhibitors"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Pulmonary Disease, Chronic Obstructive"
    }
  ]
}